NFKB1 and cancer: Cholesterol synthesis inhibitor, farnesyltransferase inhibitor and COX-2 inhibitor, decrease CD44, CD133 and ALDH1A1 levels, inhibit Akt and NF-κB activation, inhibit cancer cell spheroid formation and promote apoptosis Xu X. T. et al. (2021)